Azithromycin Teva

Medicinal product

(Invented) name

Azithromycin Teva

Active substance (s)

Azitromicinas

Strength

250 mg

Pharmaceutical form

disperguojamosios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01FA10, Azithromycin

Marketing authorisation holder

Teva Pharma B.V., Nyderlandai

Date of authorisation

2017-07-10

Date of renewal

Documents

4093_3_6, 9_12 Pakuotės lapelis 191211.docx

4093_3_6, 9_12 Azithromycin Teva disperg PL 191211.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

PL/H/0423/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Azitromicinas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68722	83305	1083305	lizdinė plokštelė	N3		Receptinis	LT/1/17/4093/003	Netiekiama	-	-	No	-	-
68723	83306	1083306	lizdinė plokštelė	N6		Receptinis	LT/1/17/4093/004	Netiekiama	-	-	No	-	-	Download
68724	83307	1083307	lizdinė plokštelė	N12		Receptinis	LT/1/17/4093/005	Netiekiama	-	-	No	-	-
68725	83308	1083308	lizdinė plokštelė	N24		Receptinis	LT/1/17/4093/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-04-29	Išregistruotas
2017-07-10	Registruotas